Nostrum Laboratories Inc. is recalling 6,958 bottles of Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, a prescription drug used to manage blood sugar in adults with type 2 diabetes. The recall was initiated because the product contains N-Nitrosodimethylamine (NDMA) at levels that exceed the acceptable daily intake limit. These tablets are sold in 100-count white plastic bottles with NDC number 29033-056-01. Consumers should consult their doctor or pharmacist immediately for an alternative treatment, as it could be dangerous to stop taking this medication without a replacement.
The tablets contain a impurity called NDMA, which is classified as a probable human carcinogen based on laboratory tests. Long-term exposure to levels above the acceptable limit may increase the risk of developing cancer.
Return to pharmacy for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.